Hochhaus, A., Müller, M. C., & Reiter, A. (2015). Nilotinib in patients with systemic mastocytosis: Analysis of the phase 2, open-label, single-arm nilotinib registration study. Journal of cancer research and clinical oncology, 141(11), . https://doi.org/10.1007/s00432-015-1988-0
Chicago-Zitierstil (17. Ausg.)Hochhaus, Andreas, Martin Christian Müller, und Andreas Reiter. "Nilotinib in Patients with Systemic Mastocytosis: Analysis of the Phase 2, Open-label, Single-arm Nilotinib Registration Study." Journal of Cancer Research and Clinical Oncology 141, no. 11 (2015). https://doi.org/10.1007/s00432-015-1988-0.
MLA-Zitierstil (9. Ausg.)Hochhaus, Andreas, et al. "Nilotinib in Patients with Systemic Mastocytosis: Analysis of the Phase 2, Open-label, Single-arm Nilotinib Registration Study." Journal of Cancer Research and Clinical Oncology, vol. 141, no. 11, 2015, https://doi.org/10.1007/s00432-015-1988-0.